Influenza vaccination has been on the decline since 2023, especially in many priority risk groups. Vaccination is a safe and effective way to protect against serious disease caused by influenza, and the flu vaccine is recommended for everyone aged 6 months and over. Flu vaccine can be given anytime, but the highest level of protection happens in the first three to four months after vaccination.
This webpage contains information and resources to support you and your team throughout the 2025 influenza vaccination season.
2025 NIP flu vaccine supply delays
The National Immunisation Program (NIP) has experienced a short delay in the supply of Vaxigrip® Tetra until early April.
FluQuadri® vaccine will be supplied as an alternative for children 6 months to under 5 years until the supply of Vaxigrip® Tetra becomes available.
Due to the late addition of FluQuadri® to the NIP, vaccine packaging will not be labelled with “Government Funded Program – 2025” like other NIP flu vaccines. Immunisation providers must ensure this vaccine is clearly labelled as NIP-funded and only used for children aged 6 months to less than 5 years.
2025 NIP influenza program resources have been updated to include this change, including: ATAGI statement, NIP program advice, NSW Health website, and the Department website.
For clinical advice, refer to the Australian Immunisation Handbook Influenza (flu) chapter.